Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pacira Pharm Inc (NQ: PCRX )

37.50 -1.58 (-4.04%)
Streaming Delayed Price Updated: 3:07 PM EDT, Jun 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 527,348
Open 39.25
Bid (Size) 37.49 (1)
Ask (Size) 37.55 (2)
Prev. Close 39.08
Today's Range 37.16 - 39.61
52wk Range 35.35 - 64.63
Shares Outstanding 44,454,792
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pacira BioSciences to Participate in Fireside Chat at the 2023 Jefferies Healthcare Conference
From Pacira BioSciences
Via GlobeNewswire
Looking Into Pacira BioSciences's Return On Capital Employed
 
Via Benzinga

Performance

YTD
-3.50%
-3.50%
1 Month
-11.26%
-11.26%
3 Month
-7.20%
-7.20%
6 Month
-20.16%
-20.16%
1 Year
-38.16%
-38.16%

More News

Read More
Pacira BioSciences to Participate in Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference
From Pacira BioSciences
Via GlobeNewswire
Recap: Pacira BioSciences Q1 Earnings
Via Benzinga
What 6 Analyst Ratings Have To Say About Pacira BioSciences
Via Benzinga
Analyst Expectations for Pacira BioSciences's Future
Via Benzinga
Earnings Preview For Pacira BioSciences
Via Benzinga
Where Pacira BioSciences Stands With Analysts
Via Benzinga
Why Pacira BioSciences Shares Are Trading Lower Today
Via Benzinga
Pacira BioSciences Reports First Quarter 2023 Financial Results
From Pacira BioSciences
Via GlobeNewswire
Pacira to Report First Quarter 2023 Financial Results on Wednesday May 3, 2023
From Pacira BioSciences
Via GlobeNewswire
Pacira BioSciences Partners with The Invited Celebrity Classic – a PGA TOUR Champions Event – to Make iovera° The Official Non-Opioid Pain Management Partner
From Pacira BioSciences
Via GlobeNewswire
Pacira BioSciences, Inc. Appoints Christopher Young as Chief Manufacturing Officer
From Pacira BioSciences
Via GlobeNewswire
Pacira BioSciences to Participate in Fireside Chat at the 22nd Annual Needham Virtual Healthcare Conference
From Pacira BioSciences
Via GlobeNewswire
Pacira BioSciences Announces Repayment and Termination of Term Loan B Facility Using Proceeds from New $150 Million 5-Year Term Loan A Facility and Existing Cash Resources
From Pacira BioSciences
Via GlobeNewswire
Pacira Announces FDA Acceptance of sNDA for Exparel Nerve Blocks to Produce Regional Analgesia in Lower Extremity Procedures
From Pacira BioSciences
Via GlobeNewswire
Third Circuit Court Upholds Decision to Dismiss Pacira BioSciences, Inc. Lawsuit
From Pacira BioSciences
Via GlobeNewswire
Pacira BioSciences Announces Yvonne Greenstreet to Retire from Board of Directors
From Pacira BioSciences
Via GlobeNewswire
Pacira BioSciences to Participate in Fireside Chat at the 2023 Barclays Global Healthcare Conference
From Pacira BioSciences
Via GlobeNewswire
Pacira BioSciences Reports Full-Year and Fourth Quarter 2022 Financial Results
From Pacira BioSciences
Via GlobeNewswire
LPGA, Pacira BioSciences Partner to Raise Awareness of Non-Opioid Pain Management Solutions
From Pacira BioSciences
Via GlobeNewswire
Earnings Scheduled For February 28, 2023
Via Benzinga
Pacira to Report 2022 Financial Results on Tuesday February 28, 2023
From Pacira BioSciences
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.